Cent Eur J Public Health 2020, 28(3):245 | DOI: 10.21101/cejph.a5284

Tuberculosis drug resistance in Canakkale, Turkey

Tanseli Gonlugur1, Gulin Basol2, Ugur Gonlugur3
1 Canakkale City Hospital, Canakkale, Turkey
2 Public Health Agency of Canakkale, Canakkale, Turkey
3 18 Mart University, Canakkale, Turkey

Received: December 16, 2017; Revised: July 14, 2020; Accepted: July 14, 2020; Published: September 30, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Gonlugur T, Basol G, Gonlugur U. Tuberculosis drug resistance in Canakkale, Turkey. Cent Eur J Public Health. 2020;28(3):245. doi: 10.21101/cejph.a5284. PubMed PMID: 32997482.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Cavusoglu C, Turhan A, Akinci P, Soyler I. Evaluation of the Genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis isolates. J Clin Microbiol. 2006;44(7):2338-42. Go to original source... Go to PubMed...
    2. Aktas E, Durmaz R, Yang D, Yang Z. Molecular characterization of isoniazid and rifampin resistance of Mycobacterium tuberculosis clinical isolates from Malatya, Turkey. Microb Drug Resist. 2005;11(2):94-9. Go to original source... Go to PubMed...
    3. Forrest GN, Tamura K. Rifampin combination therapy for nonmycobacterial infections. Clin Microbiol Rev. 2010;23(1):14-34. Go to original source... Go to PubMed...
    4. Cakir E, Erdem E, Ozlu N, Seber E, Gencer S, Kilicaslan Z. Demographic and microbial characteristics and drug resistance of childhood tuberculosis in Istanbul: analysis of 1,541 cases. J Infect Dev Ctries. 2014;8(3):304-9. Go to original source... Go to PubMed...
    5. Aydin F, Kaklikkaya N, Bayramoğlu G, Ozkul G, Buruk K, Dinç U, et al. Resistance rates of Mycobacterium tuberculosis complex strains isolated from clinical specimens. Mikrobiyol Bul. 2011;45(1):36-42. (In Turkish.) Go to PubMed...
    6. Tatman Otkun M, Akçali A, Karadenizli A, Ozbey N, Gazel D, Sener A, et al. Epidemiological evaluation of a rapidly-prevented tularemia outbreak in Canakkale province, Turkey. Mikrobiyol Bul. 2011;45(1):48-57. (In Turkish.) Go to PubMed...
    7. Glasauer S, Altmann D, Hauer B, Brodhun B, Haas W, Perumal N. First-line tuberculosis drug resistance patterns and associated risk factors in Germany, 2008-2017. PLoS One 2019;14(6):e0217597. doi: 10.1371/journal.pone.0217597. Go to original source... Go to PubMed...
    8. Gutiérrez-Aroca JB, Ruiz P, Vaquero M, Causse M, Casal M. Surveillance of drug-resistant tuberculosis in Spain (2001-2015). Microb Drug Resist. 2018;24(6):839-43. Go to original source... Go to PubMed...
    9. Bajrami R, Mulliqi G, Kurti A, Lila G, Raka L. Drug resistance profile of Mycobacterium tuberculosis isolates from patients referred to tuberculosis reference laboratory in Kosovo. Int J Mycobacteriol 2019;8(1):22-4. Go to original source... Go to PubMed...

    Return to the content